RGCC South East Asia

RGCC was launched in 2004 by genetics pioneer Dr. Ioannis Papasotiriou who believes that the key to effectively treating cancer lies in personalised medicine using the information in a patient’s genes.

Using world-leading technology, equipment and innovative techniques, our team of scientists have developed a range of tests that give healthcare professionals comprehensive information about a patient’s genetics, physiology and immune profiles. This diversion from a ‘one-size-fits all approach’ uses data to determine what treatment will work best.

Most importantly, by looking at a person’s genetics, physiology and immune profiles, our cost-effective and highly accurate tests will give you the information you need to formulate effective personalised treatment plans.